Kawchak, K. (2026). From Independent Scientist to Novel Performer: A Small-Business Operating, Milestone, and Capitalization Plan for a Phase 1 LLM-Advised Robotic Whipple. Zenodo. https://t.co/jyyWR9Clyz
Kawchak, K. (2026). 10 Funding Applications: A Phase 1, First-in Human, PDAC Clinical Trial Protocol of a LLM-Directed Robotic Whipple with Daraxonrasib (RMC-6236). Zenodo. https://t.co/hLwROJqjvc
2024-2026 ChemicalQDevice publications in figures. Additional insights, 53 abstracts, and full-size images are available through GitHub: https://t.co/hCTXDyT00a.
Kawchak, K. (2026). Investigational New Drug Application - Daraxonrasib, Phase 1, LLM-Directed Robotic Whipple in KRAS-Mutated PDAC. Zenodo. https://t.co/d7bJSNyi2h